Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q2 2017 · 10-Q
Revenue$642.00K$642.00Kno prior Q2 2016 on file Net Income-$498.19K-$498.19KN/M vs Q2 2016 EPS Diluted-$0.55-$0.55N/M vs Q2 2016 Operating Income-$479,623— Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin-74.7%
Net margin-77.6%
ended Jun 30, 2017 · filed Aug 14, 2017 · 45 d after period end